| Literature DB >> 27752556 |
David C Mackenzie1, Vicki E Noble2.
Abstract
Resuscitation with intravenous fluid can restore intravascular volume and improve stroke volume. However, in unstable patients, approximately 50% of fluid boluses fail to improve cardiac output as intended. Increasing evidence suggests that excess fluid may worsen patient outcomes. Clinical examination and vital signs are unreliable predictors of the response to a fluid challenge. We review the importance of fluid management in the critically ill, methods of evaluating volume status, and tools to predict fluid responsiveness.Entities:
Keywords: Hemodynamics; Shock; Ultrasonography
Year: 2014 PMID: 27752556 PMCID: PMC5052829 DOI: 10.15441/ceem.14.040
Source DB: PubMed Journal: Clin Exp Emerg Med ISSN: 2383-4625
Fig. 1.(A) Frank-Starling curve. Static measures of preload reflect an individual’s cardiac output at a given time point, but cannot inform the clinician if the patient has preload reserve (points X and Y) or is preload independent (Z). (B) Tests of fluid responsiveness should challenge an individual’s FrankStarling relationship, and assess potential to advance along the curve (from 1 to 2).
Static and dynamic hemodynamic parameters
| Static parameters | Central venous pressure |
| Pulmonary artery occlusion pressure | |
| Inferior vena cava (IVC) diameter | |
| IVC collapsibility/distensibility | |
| End-diastolic volume | |
| Corrected flow time | |
| Dynamic parameters | Pulse pressure variation |
| Stroke volume variation | |
| Plethysmographic variability index | |
| Modified fluid challenge | Passive leg raise |
| Mini fluid bolus (100−200 mL) |
Fig. 2.Passive leg raise. To perform a passive leg raise, a patient is placed in a semi-recumbent position at 45°. The patient’s legs are then elevated to 45° and the hemodynamic variable of interest evaluated after 30−60 seconds.
Fig. 3.Measurement of the inferior vena cava (IVC) caval index. (A) Long axis view of the IVC. The diameter is measured with M-mode 2−3 cm distal to the confluence of the hepatic vein and IVC. (B) M-mode tracing of the IVC demonstrating respirophasic changes in diameter.
Techniques and monitors for evaluating fluid responsiveness
| Parameter | Monitor |
|---|---|
| Passive leg raise | Echocardiography, CardioQ (esophageal Doppler), NICOM, PiCCO, Vigileo FloTrac |
| Pulse pressure variation | LiDCO, Clearsight (Nexfin), PRAM |
| Stroke volume variation | LiDCO, PiCCO, Pulsioflex, PRAM, Vigileo FloTrac, VolumeView |
| Pleth variability index | Masimo Radical7 |
Hemodynamic monitoring systems
| Technology | Device | Invasiveness | Principle | Advantage | Disadvantage |
|---|---|---|---|---|---|
| Bioreactance | NICOM | Non-invasive | Bioreactance | Non-invasive. Continuous CO measurements. | Fewer validation studies. Accuracy may be decreased in critical illness. |
| Plethymosgraphic wave form analysis | Radical7 | Non-invasive | Plethysmograph wave form analysis | Continuous CO measurements. Easy to use. Non-invasive. | Decreased accuracy with poor perfusion. Requires calibration. Validated in ventilated patients with TV >8 mL/kg in SR. |
| Pulmonary artery catheter | Vigilance | Central arterial catheter | Thermodilution | Measurement of multiple hemodynamic parameters. CO measurement gold standard. | Highly invasive. Intermittent CO measurements. Poor predictor of fluid responsiveness. |
| Pulse contour analysis | FloTrac | Arterial catheter | Pulse wave analysis | Continuous CO measurements. No calibration requirement. Easy use. | In consistent CO tracking. Decreased accuracy with decreased vascular resistance. Validated in ventilated patients with TV >8 mL/kg in SR. |
| LiDCO | Arterial catheter | Lithium dilution | Continuous CO measurements. Performs well in broad range of patient conditions. | Requires frequent calibration. Validated in ventilated patients with TV >8 mL/kg in SR. | |
| PiCCO | Central arterial & venous catheters | Thermodilution | Continuous CO measurements. Performs well in broad range of patient conditions. | In vasive. Requires calibration. Validated in ventilated patients with TV >8 mL/kg in SR. | |
| PRAM | Arterial catheter | Pulse wave analysis | No calibration. Continuous CO measurements. | Few studies validating use. | |
| Clearsight/Nexfin | Non-invasive | Pulse wave analysis | Non-invasive. Continuous CO measurements. | Decreased accuracy in critical illness. Few validation studies. | |
| Volume view | Central arterial & venous catheters | Thermodilution | Continuous CO measurements. | In vasive. Requires calibration. Validated in ventilated patients with TV >8 mL/kg in SR. | |
| Ultrasound | Cardio Q | Esophageal probe | Doppler ultrasound | Well validated. Continuous CO measurements. | Operator dependent. Most patients require intubation. |
| USCOM | Non-invasive | Doppler ultrasound | Non-invasive | Operator dependent. Intermittent CO measurement. |
CO, cardiac output; TV, tidal volume; SR, sinus rhythm.
Fig. 4.Measurement of aortic velocity-time integral (VTI). (A) Apical 5-chamber view of the heart, demonstrating position for Doppler measurement of aortic blood flow. (B) Spectral Doppler tracing of aortic blood flow. The area under the curve is the VTI.